The impact of acquisition time of planar cardiac (123)I-MIBG imaging on the late heart to mediastinum ratio

Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):326-332. doi: 10.1007/s00259-015-3220-5. Epub 2015 Oct 29.

Abstract

Purpose: The aim of this study was to investigate whether performing the late cardiac (123)I-metaiodobenzylguanidine (MIBG) scan earlier than 4 h post-injection (p.i.) has relevant impact on the late heart to mediastinum ratio (H/M ratio) in patients with heart failure (HF).

Methods: Forty-nine patients with HF (median left ventricular ejection fraction of 31 %, 51 % ischaemic HF) referred for cardiac (123)I-MIBG scintigraphy were scanned at 15 min (early) p.i. and at 1, 2, 3 and 4 h (late) p.i. of (123)I-MIBG. Late H/M ratios were calculated and evaluated using a linear mixed model with the mean late H/M ratio at 4 h p.i. as a reference. A difference in late H/M ratios of more than 0.10 between the different acquisition times in comparison with the late H/M ratio at 4 h p.i. was considered as clinically relevant.

Results: Statistically significant mean differences were observed between the late H/M ratios at 1, 2 and 3 h p.i. compared with the late H/M ratio at 4 h p.i. (0.09, 0.05 and 0.02, respectively). However, the mean differences did not exceed the cut-off value of 0.10. On an individual patient level, compared to the late H/M ratio at 4 h p.i., the late H/M ratios at 1, 2 and 3 h p.i. differed more than 0.10 in 24 (50 %), 9 (19 %) and 2 (4 %) patients, respectively.

Conclusion: Variation in acquisition time of (123)I-MIBG between 2 and 4 h p.i. does not lead to a clinically significant change in the late H/M ratio. An earlier acquisition time seems to be justified and may warrant a more time-efficient cardiac (123)I-MIBG imaging protocol.

Keywords: 123I-MIBG; Acquisition time; Heart failure; Heart to mediastinum ratio; Planar imaging.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Iodobenzylguanidine / administration & dosage*
  • Adolescent
  • Adult
  • Aged
  • Drug Administration Schedule
  • Female
  • Heart / diagnostic imaging*
  • Heart Failure / diagnostic imaging*
  • Humans
  • Male
  • Mediastinum / diagnostic imaging*
  • Middle Aged
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals / administration & dosage*

Substances

  • Radiopharmaceuticals
  • 3-Iodobenzylguanidine